Pharma sector company Divi's Laboratories has released its quarterly results. The company's profit has increased by 47 percent compared to last year. At the same time, income has seen a growth of 23 percent on a year-on-year basis. EBITDA has registered a sharp jump of 50 percent during this period. At the same time, a good increase has also been seen in the margin. The company's results have been better than the market estimates. The company's income, profit and EBITDA have been more than 4 percent above all estimates. The company has released its results on Saturday. Before the results, Divi's Lab's stock closed at 5938 with a decline of 0.3 percent in Friday's trading.

How were the quarterly results?

 

According to the information given by the company, the profit has been Rs 510 crore with a growth of 46.5 percent compared to last year. A year ago, the company's profit was Rs 348 crore. Income has been Rs 2338 crore with a growth of 22.5 percent on a year-on-year basis, which was at Rs 1909 crore a year ago. EBITDA has increased by 49.5 percent to Rs 716 crore compared to last year. In the same quarter last year, EBITDA was at Rs 479 crore. At the same time, margins have reached 30.6 percent, which was at 25 percent a year ago. How were the results compared to market estimates? The company's results have been better than market estimates. The company's quarterly income has been 4.2 percent higher than the estimate received in the CNBC TV 18 poll. At the same time, the income has been 4.4 percent more than the estimates. The EBITDA figure has been 6.9 percent higher than the market estimate. At the same time, the company's margins stood at 30.6 percent, the estimate was 30 percent.